Skip to main content

Table 3 Mean (SD) [range] measured and estimated dose rates and dose rate per MBq administered activity at 0.1 and 1 m from the mid-abdomen

From: Radiation precautions for inpatient and outpatient 177Lu-DOTATATE peptide receptor radionuclide therapy of neuroendocrine tumours

  Time (hours) Dose rate (μSv/h) Dose rate per MBq (nSv/h/MBq)
0.1 m 1 m 0.1 m 1 m
177Lu-DOTATATE Mallinckrodt
Inpatient measured
0 407 (83)
[250–750]
20 (2)
[15–25]
58 (12)
[35–99]
3 (0.3)
[2.1–3.6]
177Lu-DOTATATE Mallinckrodt
Inpatient estimated
18.1 148 (77)
[49–334]
7 (3)
[4–15]
21 (11)
[5–46]
1 (0.5)
[0.4–2]
177Lu-DOTATATE Mallinckrodt
Outpatient estimated
5.2 258 (75)
[100–435]
13 (3)
[6–20]
37 (10)
[14–60]
2 (0.4)
[0.8–3]
Lutathera® AAA
Outpatient measured
5.7 15 (5)
[5–25]
2 (0.6)
[0.6–3]